CIK 0001680048
- Non-accelerated filer
- Smaller reporting company
MUSTANG BIO, INC.
Sign in to watch- Ticker
- MBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 473828760
- Phone
- +1 781-652-4500
- Business address
- 95 SAWYER RD, SUITE 110, WALTHAM, MA, 02453
- 4 Grant or award Director acquired 13,774 shares (grant or award)
- 4 Grant or award President and CEO acquired 61,000 shares (grant or award)
- 4 Grant or award Director acquired 13,774 shares (grant or award)
- 4 Grant or award Director acquired 13,774 shares (grant or award)
- 4 Open-market sale President and CEO sold 12,373 shares at $3.04 ($37,614)
- 4 Open-market sale SVP, Fin. & Corp. Controller sold 20,721 shares at an average $3.20 ($66,282)
- 4 Open-market buy President and CEO bought 165,562 shares at $3.12 ($516,553)
- 4 Grant or award Director acquired 1,043 shares (grant or award)
- 4 Grant or award SVP, Fin. & Corp. Controller acquired 22,500 shares (grant or award)
- 4/A Open-market buy Director bought 100,000 shares at $2.66 ($266,000)
- 4/A Grant or award Director acquired 17,442 shares (grant or award)
- 4 Open-market buy President and CEO bought 100,000 shares at $2.91 ($291,000)
- 4 Open-market buy Director bought 100,000 shares at $2.66 ($266,000)
- 4 Grant or award Director acquired 16,611 shares (grant or award)
- 4 Grant or award Director acquired 16,611 shares (grant or award)
- 4 Grant or award Director acquired 16,611 shares (grant or award)
- 4 Grant or award Director acquired 16,611 shares (grant or award)
- 4 Grant or award Director acquired 16,611 shares (grant or award)
- 4 Open-market buy President and CEO bought 153,846 shares at $3.25 ($500,000)
- 4 Open-market buy President and CEO bought 180,000 shares at an average $2.96 ($532,800)
Page 3 of 5 · 85 filings